Danielle Spencer, PA
Physician Assistant · Topeka, KSNPI 1952969925
Payments from drug & device makers
Across 112 payments — averaging $21.26 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Johnson & Johnson$263
- Novartis$240
- GSK$181
- Sobi, Inc$162
- AbbVie$155
- Takeda Pharmaceuticals U.S.A., Inc.$138
- plus $1K from 31 others
What the payments were for
- Food & beverage$2,21293%
- Education$1707%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Johnson & Johnson | 9 | $263 |
| Novartis | 11 | $240 |
| GSK | 10 | $181 |
| Sobi, Inc | 5 | $162 |
| AbbVie | 7 | $155 |
| Takeda Pharmaceuticals U.S.A., Inc. | 5 | $138 |
| Pfizer | 6 | $118 |
| Merck | 5 | $101 |
| Incyte Corporation | 5 | $94 |
| Array Biopharma Inc | 4 | $77 |
| Seagen Inc. | 4 | $74 |
| Ipsen Biopharmaceuticals, Inc | 2 | $63 |
| Bristol Myers Squibb | 4 | $59 |
| E.r. Squibb & Sons, L.L.C. | 4 | $57 |
| Genmab U.S., Inc. | 2 | $46 |
| AstraZeneca | 2 | $44 |
| Syndax Pharmaceuticals, Inc. | 2 | $42 |
| Puma Biotechnology, Inc. | 2 | $39 |
| Rigel Pharmaceuticals, Inc. | 2 | $36 |
| Stemline Therapeutics Inc. | 2 | $36 |
| Pharmacosmos Therapeutics Inc. | 2 | $34 |
| Myriad Genetic Laboratories, Inc. | 2 | $29 |
| Lilly USA, LLC | 1 | $28 |
| Amgen | 1 | $26 |
| Tersera Therapeutics LLC | 1 | $25 |
| Taiho Oncology, Inc. | 1 | $23 |
| Sun Pharmaceutical Industries Inc. | 1 | $22 |
| Bayer | 1 | $21 |
| Springworks Therapeutics, Inc. | 1 | $19 |
| Novocure Inc. | 1 | $19 |
| Sumitomo Pharma America, Inc. | 1 | $19 |
| AVEO Pharmaceuticals, Inc. | 1 | $17 |
| Apellis Pharmaceuticals, Inc. | 1 | $17 |
| Gilead | 1 | $15 |
| Astellas Pharma US Inc | 1 | $15 |
| Beigene USA, Inc. | 1 | $14 |
| G1 Therapeutics, Inc. | 1 | $14 |
How this compares
$2,382 in reported general payments places this provider in the 80th percentile of 1,016 physician assistant providers in Kansas.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| XtandiEnzalutamide | 25 | $356,634 |
| KisqaliRibociclib Succinate | 13 | $184,461 |
| ImbruvicaIbrutinib | 13 | $127,047 |
| EliquisApixaban | 41 | $31,370 |
| VenclextaVenetoclax | 11 | $12,651 |
| PegasysPeginterferon Alfa-2a | 11 | $12,191 |
| Fentanyl | 35 | $2,843 |
| Exemestane | 20 | $2,474 |
| Anastrozole | 153 | $2,032 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 55 | $1,495 |
| Letrozole | 50 | $1,327 |
| Methylphenidate Hcl | 41 | $1,015 |
| Diphenoxylate-AtropineDiphenoxylate Hcl/Atropine | 28 | $812 |
| Levothyroxine Sodium | 89 | $788 |
| Hydroxyurea | 34 | $745 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Astellas Pharma US IncXtandi | $15 | $356,63425 claims |
| NovartisKisqali | $240 | $184,46113 claims |
| PfizerEliquis | $118 | $31,37041 claims |
| AbbVieVenclexta | $155 | $12,65111 claims |
| Lilly USA, LLCOlanzapine | $28 | $33011 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 1,016 physician assistant providers in Kansas.
Other physician assistant in Topeka
- Dylan TimmermannTopeka$19K
- Jay GrayTopeka$10K
- Sierra FergusonWichita$25K
- Heather HowellKansas City$16K
- Amy BrettmanShawnee$14K
- Ashton YoungersWichita$14K
- Anthony GunawanLakin$13K
- Therese SchrandtWichita$13K
- Mike HallWichita$13K
- Melissa WilkesFort Riley$13K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.